FI120136B - Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi - Google Patents
Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi Download PDFInfo
- Publication number
- FI120136B FI120136B FI991384A FI991384A FI120136B FI 120136 B FI120136 B FI 120136B FI 991384 A FI991384 A FI 991384A FI 991384 A FI991384 A FI 991384A FI 120136 B FI120136 B FI 120136B
- Authority
- FI
- Finland
- Prior art keywords
- vaccae
- ova
- activity
- mice
- response
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9626215 | 1996-12-18 | ||
GBGB9626215.9A GB9626215D0 (en) | 1996-12-18 | 1996-12-18 | A therapeutic agent and its use |
GB9626859 | 1996-12-24 | ||
GBGB9626859.4A GB9626859D0 (en) | 1996-12-24 | 1996-12-24 | Medical treatment |
GB9703460 | 1997-12-17 | ||
PCT/GB1997/003460 WO1998026790A1 (en) | 1996-12-18 | 1997-12-17 | Mycobacterium vaccae for down-regulation of the th2 activity of the immune system |
Publications (3)
Publication Number | Publication Date |
---|---|
FI991384A FI991384A (fi) | 1999-06-17 |
FI991384A0 FI991384A0 (fi) | 1999-06-17 |
FI120136B true FI120136B (fi) | 2009-07-15 |
Family
ID=26310662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI991384A FI120136B (fi) | 1996-12-18 | 1999-06-17 | Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0951289B1 (no) |
JP (1) | JP4358306B2 (no) |
KR (1) | KR100533818B1 (no) |
CN (1) | CN1129453C (no) |
AP (1) | AP1044A (no) |
AT (1) | ATE307600T1 (no) |
AU (1) | AU730548B2 (no) |
BR (1) | BR9713959A (no) |
CA (1) | CA2273848C (no) |
DE (1) | DE69734461T2 (no) |
DK (1) | DK0951289T3 (no) |
ES (1) | ES2251744T3 (no) |
FI (1) | FI120136B (no) |
HK (1) | HK1021316A1 (no) |
NO (1) | NO321202B1 (no) |
NZ (1) | NZ336147A (no) |
RU (1) | RU2197989C2 (no) |
WO (1) | WO1998026790A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6361776B1 (en) * | 1999-12-06 | 2002-03-26 | Genesis Research & Development Corp. Ltd. | Compounds isolated from M. vaccae and their use in modulation of immune responses |
WO2001097821A1 (en) * | 2000-06-19 | 2001-12-27 | Mucoprotec Pty Ltd | Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
AUPR101600A0 (en) * | 2000-10-25 | 2000-11-16 | Atheromastat Pty Ltd | Compositions and methods for diagnosis and treatment of cardiovascular disorders |
DE60235971D1 (de) | 2001-02-20 | 2010-05-27 | Maruho Kk | Neue medizinische verwendung von alpha-antigen oder alpha-antigen-gen |
AU2016281765B2 (en) * | 2015-06-24 | 2022-06-16 | Immodulon Therapeutics Limited | A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy |
US11077179B2 (en) | 2017-08-10 | 2021-08-03 | Epicgenetics, Inc. | Method for treating fibromyalgia and chronic fatigue syndrome |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL71683A0 (en) * | 1984-04-27 | 1984-09-30 | Yeda Res & Dev | Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria |
GB9219425D0 (en) * | 1992-09-14 | 1992-10-28 | Univ London | Therapeutic agent and its use |
GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
ATE154759T1 (de) * | 1990-11-08 | 1997-07-15 | Univ London | Mycobacterium als adjuvans für antigene |
GB9203814D0 (en) * | 1992-02-21 | 1992-04-08 | Univ London | Treatment of long term auto-immune conditions |
GB9406301D0 (en) * | 1994-03-30 | 1994-05-25 | Univ London | Immunotherapeutic agent and its use |
AUPM864894A0 (en) * | 1994-10-07 | 1994-11-03 | Borody, Thomas Julius | Treatment of bowel-dependent neurological disorders |
-
1997
- 1997-12-17 CA CA002273848A patent/CA2273848C/en not_active Expired - Fee Related
- 1997-12-17 RU RU99116029/14A patent/RU2197989C2/ru not_active IP Right Cessation
- 1997-12-17 CN CN97181765A patent/CN1129453C/zh not_active Expired - Fee Related
- 1997-12-17 ES ES97949067T patent/ES2251744T3/es not_active Expired - Lifetime
- 1997-12-17 AU AU77355/98A patent/AU730548B2/en not_active Ceased
- 1997-12-17 NZ NZ336147A patent/NZ336147A/en not_active IP Right Cessation
- 1997-12-17 KR KR10-1999-7005412A patent/KR100533818B1/ko not_active IP Right Cessation
- 1997-12-17 JP JP52745698A patent/JP4358306B2/ja not_active Expired - Fee Related
- 1997-12-17 EP EP97949067A patent/EP0951289B1/en not_active Expired - Lifetime
- 1997-12-17 AT AT97949067T patent/ATE307600T1/de active
- 1997-12-17 BR BR9713959-9A patent/BR9713959A/pt not_active IP Right Cessation
- 1997-12-17 DK DK97949067T patent/DK0951289T3/da active
- 1997-12-17 WO PCT/GB1997/003460 patent/WO1998026790A1/en active IP Right Grant
- 1997-12-17 DE DE69734461T patent/DE69734461T2/de not_active Expired - Lifetime
- 1997-12-17 AP APAP/P/1999/001553A patent/AP1044A/en active
-
1999
- 1999-06-17 FI FI991384A patent/FI120136B/fi not_active IP Right Cessation
- 1999-06-17 NO NO19992957A patent/NO321202B1/no not_active IP Right Cessation
- 1999-12-24 HK HK99106112A patent/HK1021316A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2273848C (en) | 2008-02-19 |
DE69734461D1 (de) | 2005-12-01 |
KR100533818B1 (ko) | 2005-12-07 |
FI991384A (fi) | 1999-06-17 |
AP1044A (en) | 2002-02-18 |
CN1129453C (zh) | 2003-12-03 |
DK0951289T3 (da) | 2006-03-13 |
CA2273848A1 (en) | 1998-06-25 |
WO1998026790A1 (en) | 1998-06-25 |
AU730548B2 (en) | 2001-03-08 |
ES2251744T3 (es) | 2006-05-01 |
ATE307600T1 (de) | 2005-11-15 |
CN1246056A (zh) | 2000-03-01 |
AU7735598A (en) | 1998-07-15 |
JP4358306B2 (ja) | 2009-11-04 |
JP2001506256A (ja) | 2001-05-15 |
RU2197989C2 (ru) | 2003-02-10 |
KR20000069518A (ko) | 2000-11-25 |
DE69734461T2 (de) | 2006-07-06 |
EP0951289A1 (en) | 1999-10-27 |
HK1021316A1 (en) | 2000-06-09 |
BR9713959A (pt) | 2000-04-11 |
EP0951289B1 (en) | 2005-10-26 |
NO321202B1 (no) | 2006-04-03 |
NO992957D0 (no) | 1999-06-17 |
NZ336147A (en) | 2001-03-30 |
NO992957L (no) | 1999-08-10 |
FI991384A0 (fi) | 1999-06-17 |
AP9901553A0 (en) | 1999-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8512694B2 (en) | Method of producing rough strains of bacteria and uses thereof | |
WO2001037865A1 (en) | Compositions and methods for treatment of allergic disorders | |
Agrawal et al. | Flt3 ligand: a novel cytokine prevents allergic asthma in a mouse model | |
FI120136B (fi) | Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi | |
Burns et al. | Immunology and infectious disease | |
Turner et al. | In vitro investigations in asthmatic children undergoing hyposensitization with tyrosine‐adsorbed Dermatophagoides pteronyssinus antigen | |
US6878377B2 (en) | Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system | |
US6723327B1 (en) | Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae | |
JP5523685B2 (ja) | 使用 | |
CN104411326A (zh) | 抗哮喘的mtb-c疫苗 | |
MXPA99005553A (en) | Mycobacterium vaccae | |
Moore et al. | Effect of antimacrophage serum on dermal tuberculin sensitivity and allergic pulmonary granuloma formation in rabbits | |
Burrows et al. | Oral administration of PPC enhances antigen-specific CD8+ T cell responses while reducing IgE levels in sensitized mice | |
HU226255B1 (en) | Mycobacterium vaccae for down-regulation of the th2 activity of the immune system | |
US20040247622A1 (en) | Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae | |
WO2002074330A2 (en) | Mycobacterrial estracts for treating autoimmune diseases | |
KR101275227B1 (ko) | 중증근무력증 예방, 개선 또는 치료용 조성물 | |
WO2003006035A1 (en) | Anti-emetic compositions comprising mycobacterial material | |
ALBERT et al. | ALLERGY A CTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 120136 Country of ref document: FI |
|
MM | Patent lapsed |